Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Contraception
- Contraceptive failure in the United States.Contraception. 2011; 83: 397-404
- Effectiveness of long-acting reversible contraception.N Engl J Med. 2012; 366: 1998-2007
- Trends in contraceptive use worldwide 2015.2015
- What is it about intrauterine devices that women find unacceptable? Factors that make women non-users: a qualitative study.J Fam Plann Reprod Health Care. 2006; 32: 89-94
- Use of effective contraception 6 months after emergency contraception with a copper intrauterine device or ulipristal acetate — a prospective observational cohort study.Acta Obstet Gynecol Scand. 2016; 95: 887-893
- Interventions for pain with intrauterine device insertion.Cochrane Database Syst Rev. 2015;
- Medications to ease intrauterine device insertion: a systematic review.Contraception. 2016; 94: 739-759
- Reducing pain during intrauterine device insertion: a randomized controlled trial in adolescents and young women.Obstet Gynecol. 2017; 130: 795-802
- Four percent intrauterine lidocaine infusion for pain management in first-trimester abortions.Obstet Gynecol. 2006; 107: 269-275
- Intrauterine lidocaine infusion for pain management during outpatient transcervical tubal sterilization: a randomized controlled trial.Contraception. 2012; 85: 275-281
- Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion.Contraception. 2013; 88: 37-40
- Procaine and mepivacaine have less toxicity in vitro than other clinically used local anesthetics.Anesth Analg. 2003; 97 ([table of contents]): 85-90
- Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial.Hum Reprod. 2007; 22: 2647-2652
- Clinical significance of reported changes in pain severity.Ann Emerg Med. 1996; 27: 485-489
- Prospective validation of clinically important changes in pain severity measured on a visual analog scale.Ann Emerg Med. 2001; 38: 633-638
- Assessment of a simplified insertion technique for intrauterine devices.Int J Gynaecol Obstet. 2016; 134: 29-32
- Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials.Health Qual Life Outcomes. 2010; 8: 138
- Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo-controlled trial.Fertil Steril. 2015; 103: 422-427
- A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.Fertil Steril. 2012; 97 ([e1-3]): 616-622
- Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study.Contraception. 2004; 69: 407-412
- Use of the levonorgestrel releasing-intrauterine system in nulliparous women — a non-interventional study in Sweden.Eur J Contracept Reprod Health Care. 2011; 16: 126-134
☆Funding: This study has been partly funded by The European Society of Contraception and Reproductive Health (grant #ESC P-2015-B-06).
☆☆Conflicts of interest: Helena Kopp Kallner reports personal fees from Bayer and MSD outside the submitted work. All other authors declare no conflicts of interest.
★Clinical trial registration: Clinicaltrials.gov, NCT 02078063.